Extranodal NK/T-cell lymphoma (ENKTL) is a rare but aggressive subtype of non-Hodgkin lymphoma, which is derived from NK cells or T cells. There are very few cases of ENKTL invading the heart. Only 12 ...

Thus, there is an urgent need for advanced therapies for patients suffering from severe and refractory autoimmune diseases, and researchers have considered cell therapy as potentially curative ...

1Department of Obstetrics and Gynecology, Peking University Third Hospital, China 2Institute of Medical Innovation and Research, Peking University Third Hospital, Beijing, China. 3Biobank, Peking ...

1Masonic Cancer Center, Minneapolis, Minnesota. 6Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota. 7Department of ...

Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and fight cancer more effectively. They identified flaws in traditional methods, ...

In a fireside chat at the World Economic Forum (WEF) in Davos 2025, Demis Hassabis, CEO of Google DeepMind, stated, “Ultimately, my dream would be to simulate a virtual cell.” In another interview ...

A VOICENOTE claiming that the Southport murderer Axel Rudakubana has been attacked behind bars has been debunked. The Ministry of Justice confirmed to The Sun that the 18-year-old has not been ...

He won’t be allowed to walk past a cleaner for fear of attack. “He will be banged up 23 hours a day, his food will be brought to his cell and then he’ll get an hour in the yard to walk around.

It essentially hacks the immune cells, transferring its own faulty mitochondrial DNA (mtDNA) into the T-cells meant to attack it. This sneaky move weakens the immune cells, making them less ...

It is likely that Axel Rudakubana “will be in custody for all his life”, the judge who sentenced the Southport child killer said today. Mr Justice Goose handed down a minimum 52-year term for ...

has made a major breakthrough in treating a common and challenging form of cancer called diffuse large B-cell lymphoma (DLBCL). In a clinical trial known as EPCORE NHL-2, the researchers showed ...

Pathogen-fighting immune cells called tissue-resident memory CD8 T cells (TRM cells) go through a surprising transformation -- and relocation -- as they fight infections in the small intestine.